Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2515837 | 0.89 | TAAR1 (0.54) | TAAR1HTR2APOLBCTDSP1IDO1 | |
| SCHEMBL11104424 | 0.88 | MAPK1 (0.47) | TAAR1HTR2APOLBCTDSP1MAPK1 | |
| SCHEMBL11108664 | 0.85 | TAAR1 (0.47) | TAAR1HTR2APOLBCTDSP1ALDH1A1 | |
| SCHEMBL18857101 | 0.85 | TAAR1 (0.46) | TAAR1MAPK1SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL8417751 | 0.83 | TAAR1 (0.45) | TAAR1HTR2APOLBCTDSP1SMN1; SMN2 | |
| SCHEMBL8418497 | 0.81 | IDO1 (0.50) | TAAR1HTR2APOLBCTDSP1LMNA | |
| SCHEMBL6229666 | 0.81 | CA1 (0.42) | TAAR1LMNAALDH1A1CASP1IDO1 | |
| SCHEMBL12299452 | 0.81 | KCNH2 (0.53) | TAAR1IDO1CYP1A2KCNH2 | |
| SCHEMBL6123807 | 0.80 | TAAR1 (0.52) | TAAR1MAPK1SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL7931860 | 0.80 | TAAR1 (0.42) | TAAR1HTR2APOLBCTDSP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111362833-A | Dianthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof | 陕西师范大学 | 2020-07-03 | — | — | CN | claimed |
| CN-111362833-B | Double anthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof | 陕西师范大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-111362833-A | Dianthracene D-delta-A type deep blue organic fluorescent material and preparation method and application thereof | 陕西师范大学 | 2020-07-03 | — | — | CN | disclosed |
| EP-1943239-B1 | PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| EP-1943239-B1 | PHENYLENE-THIOPHENE OLIGOMERS AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-20110195999-A1 | NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND | NAKAMOTO KAZUTAKA | 2011-08-11 | — | — | US | disclosed |
| US-20110195999-A1 | NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND | NAKAMOTO KAZUTAKA | 2011-08-11 | — | — | US | disclosed |
| US-20110195999-A1 | NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND | NAKAMOTO KAZUTAKA | 2011-08-11 | — | — | US | disclosed |
| US-7932272-B2 | Antifungal agent containing heterocyclic compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-04-26 | — | — | US | disclosed |
| US-7932272-B2 | Antifungal agent containing heterocyclic compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-04-26 | — | — | US | disclosed |
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070078267-A1 | Organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070077681-A1 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070077681-A1 | Liquid phase fabrication of active devices including organic semiconductors | ALCATEL-LUCENT USA INC. | 2007-04-05 | — | — | US | disclosed |
| US-20070075630-A1 | Organic compositions | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-05 | — | — | US | disclosed |
| US-20070075630-A1 | Organic compositions | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-05 | — | — | US | disclosed |
| US-20070075630-A1 | Organic compositions | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-05 | — | — | US | disclosed |
| EP-1669348-A1 | NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND | Eisai Co., Ltd. (JP) | 2006-06-14 | — | — | EP | disclosed |
| US-4431564-A | 4'-/2-ALKYLOXYETHYL/-4-CYANOBI-OR TERPHENYLS; DISPLAYING; IODINATION AND CYANATION THE ESTER DERIVATIVE | CHISSO CORPORATION (JP) | 1984-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195999-A1 | NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND | ERG28, CYP51A1, XPO1 | TAAR1 2049/4885HTR2A 3780/4885POLB 4378/4885 |
| US-20070078267-A1 | Organic semiconductors | ORC3, C1S, C5 | TAAR1 470/4885HTR2A 1473/4885POLB 494/4885 |
| US-20070075630-A1 | Organic compositions | BPNT1, RFT1, FERMT2 | TAAR1 2677/4885HTR2A 3180/4885POLB 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.